Therapeutic developments in amyotrophic lateral sclerosis
Author:
- 1 April 1999
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 8 (4) , 347-361
Abstract
There is currently no effective treatment for amyotrophic lateral sclerosis (ALS), a devastating disorder of the human nervous system that, due to motoneurone degeneration, causes progressive loss of muscle function and death. The relentless progression of ALS and the uniformly poor prognosis have been unhindered by a variety of therapeutic agents tested in previous clinical studies. Recently, two drugs, namely riluzole and recombinant human insulin-like growth factor-I (IGF-1), have been reported to benefit patients with ALS by improving survival or slowing disease progression. Several other drugs, such as gabapentin and various neurotrophic factors, are being investigated in on-going clinical trials. Therapeutic developments in ALS have been hampered by the fact that the precise cause of the disease remains unknown. In addition, there are considerable variations in disease related characteristics among patients, rendering accurate measurements of disease progression difficult. Advances in theories of pa...Keywords
This publication has 116 references indexed in Scilit:
- Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration?Trends in Pharmacological Sciences, 1998
- Works in progress abstractsAnnals of Neurology, 1995
- Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosisNeuroscience Letters, 1995
- Riluzole and experimental parkinsonismNeuroReport, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiationAnnals of Neurology, 1994
- Activity‐Sensitive Signaling by Muscle‐Derived Insulin‐like Growth Factors in the Developing and Regenerating Neuromuscular SystemAnnals of the New York Academy of Sciences, 1993
- Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosisCell, 1993
- Motor Neuron Disease (Amyotrophic Lateral Sclerosis)Mayo Clinic Proceedings, 1991
- Neurotrophic moleculesAnnals of Neurology, 1989